Special Story: CDSCO Approved Denmark Medicine for Diabetic Heart Attack Weight Loss Treatment

ଡାଏବେଟିସ୍‌ର ନୂଆ ମେଡିସିନ୍। ଷ୍ଟ୍ରୋକ୍ ଭଳି ବିପଦକୁ ବି କମେଇବ। ଶରୀରରେ ରହିବ ନାହିଁ ମୋଟାପା। କେନ୍ଦ୍ର ସରକାର Type-2 ଡାଏବେଟିସ୍ ପାଇଁ ଡେନ୍‌ମାର୍କର ଏକ ଔଷଧକୁ ଅନୁମୋଦନ କରିଛନ୍ତି।

India's drug regulator has approved Ozempic (semaglutide) for use in adults with type-2 diabetes. Danish pharmaceutical giant Novo Nordisk is set to introduce Ozempic in India, a development that could benefit millions living with type-2 diabetes.

#SpecialStory#Ozempic#Semaglutide#NovoNordisk#DiabetesIndia#Type2Diabetes#DiabetesTreatment#BloodSugarControl#WeightLossMedication#DiabetesCare#CardiometabolicHealth#WeeklyInjection#IndiaHealth#HealthcareIndia#IndiaDiabetes#NewDrugIndia#OzempicInIndia#FDAApproved#ClinicalTrials#PharmaNews#MedicalInnovation#DiabetesNews#OTV

For latest news updates follow us on WhatsApp: https://whatsapp.com/channel/0029VaYNIW78qIzrtKKZiD3M

OdishaTV is Odisha's no 1 News Channel. OTV being the first private satellite TV channel in Odisha carries the onus of charting a course that behoves its pioneering efforts.
Accordingly its charter objectives are FREE, FAIR and UNBIASED. OTV delivers reliable information across all platforms: TV, Internet and Mobile.

Stay tuned for all the breaking news !

Visit Our Website https://odishatv.in/
News In Odia: http://otvkhabar.in/
Android App: https://bit.ly/OTVAndroidApp
iOS App: https://bit.ly/OTViOSApp
Watch Live: https://odishatv.in/live-tv
YouTube: https://goo.gl/Ehz6OP
Watch our latest news in English: https://bit.ly/3wTgKxc
Facebook: https://www.facebook.com/otvkhabar
OTV English Facebook : https://www.facebook.com/otvnews
Telegram @otvtelegram @otvkhabar
Twitter: https://twitter.com/otvnews
Instagram: https://www.instagram.com/otvnews/

#OdishaTV#OTV